Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-113208

Director sold 5,441 shares at $35.13 ($191,142)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kersten Dirk Director 2024-10-03 Sale 10b5-1 −5,441 $35.13 $191,142 123,323 I
Open-market sales · 5,441 sh · avg $35.13 · $191,142
Loading xslF345X05/ownership.xml…